Circadian rhythm and misalignment in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD): an experimental medicine approach by Marjot, T

Of mice and men: is there a future for metformin in the treatment of hepatic steatosis? by Green, C, Marjot, T, Tomlinson, J, Hodson, L

Determining risk factors for mortality in liver transplant patients with COVID-19 by Webb, GJ, Moon, AM, Barnes, E, Barritt, AS, Marjot, T

Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management by Marjot, T, Moolla, A, Cobbold, J, Hodson, L, Tomlinson, J

Non-alcoholic fatty liver disease and diabetes. by Hazlehurst, J, Woods, C, Marjot, T, Cobbold, J, Tomlinson, J

Shift work and evening chronotype are associated with hepatic fat fraction and non-alcoholic fatty liver disease in 282,303 UK biobank participants by Robert Maidstone, Martin K Rutter, Thomas Marjot, David W Ray, Matthew Baxter

Get full text

Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity by Mozes, F, Tunnicliffe, E, Moolla, A, Marjot, T, Levick, C, Pavlides, M, Robson, M

Adopting a Citizen Science Approach in Translational Experimental Medicine Research in Non-Alcoholic Fatty Liver Disease: A Study Protocol by Syed Ghulam Sarwar Shah, Yolanda Barrado-Martín, Thomas Marjot, Jeremy W. Tomlinson, Vasiliki Kiparoglou

Get full text

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes by Luke Baldelli, Thomas Marjot, Eleanor Barnes, A. Sidney Barritt, Gwilym J. Webb, Andrew M. Moon

Get full text

Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospit... by Marjot, T, Sbardella, E, Moolla, A, Hazlehurst, J, Tan, G, Ainsworth, M, Cobbold, J, Tomlinson, J

Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes by Marjot, T, Green, CJ, Charlton, CA, Cornfield, T, Hazlehurst, J, Moolla, A, White, S, Francis, J, Neubauer, S, Cobbold, JFL, Hodson, L, Tomlinson, JW

A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health by Moolla, A, Motohashi, K, Marjot, T, Shard, A, Ainsworth, M, Gray, A, Holman, R, Pavlides, M, Ryan, J, Tomlinson, J, Cobbold, J

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis by Green, CJ, Marjot, T, Walsby-Tickle, J, Charlton, C, Cornfield, T, Westcott, F, Pinnick, KE, Moolla, A, Hazlehurst, JM, McCullagh, J, Tomlinson, JW, Hodson, L

Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers by Wang, T, Smith, DA, Campbell, C, Harris, S, Salih, H, Várnai, KA, Woods, K, Noble, T, Freeman, O, Moysova, Z, Marjot, T, Webb, GJ, Davies, J, Barnes, E, Matthews, PC

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans by Westcott, F, Nagarajan, S, Parry, S, Savic, D, Green, C, Marjot, T, Johnson, E, Cornfield, T, Mozes, F, O'Rourke, P, Mendall, J, Dearlove, D, Fielding, B, Smith, K, Tomlinson, J, Hodson, L

SARS-CoV-2 infection in patients with autoimmune hepatitis by Marjot, T, Buescher, G, Sebode, M, Barnes, E, Barritt, A, Armstrong, M, Baldelli, L, Kennedy, J, Mercer, C, Ozga, A-K, Casar, C, Schramm, C, Moon, A, Webb, G, Lohse, A

Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents by Hazlehurst, JM, Lim, TR, Charlton, C, Miller, JJ, Gathercole, LL, Cornfield, T, Nikolaou, N, Harris, SE, Moolla, A, Othonos, N, Heather, LC, Marjot, T, Tyler, DJ, Carr, C, Hodson, L, McKeating, J, Tomlinson, JW

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019 by Tingyan Wang, David A. Smith, Cori Campbell, Steve Harris, Hizni Salih, Kinga A. Várnai, Kerrie Woods, Theresa Noble, Oliver Freeman, Zuzana Moysova, Thomas Marjot, Gwilym J. Webb, Jim Davies, Eleanor Barnes, Philippa C. Matthews

Get full text

Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study by Umar Hayat, Andrew M. Moon, Manesh K. Gangwani, Fariha Hasan, Thomas Marjot, A. Sidney Barritt IV, Wasique Mirza, Duane Deivert, Muhammad Aziz, Dushyant Singh Dahiya, Hassam Ali, Sumant Inamdar, Mauricio Garcia‐Saenz‐de‐Sicilia

Get full text

SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination by Andrew M. Moon, Gwilym J. Webb, Ignacio García‐Juárez, Anand V. Kulkarni, Gupse Adali, David K. Wong, Beth Lusina, George N. Dalekos, Steven Masson, Brandon M. Shore, Eleanor Barnes, A. Sidney Barritt IV, Thomas Marjot

Get full text